Publication: 2540

Publication: 2540

Integrated Analysis of Multidimensional Genomic Data on CALGB 40601 (Alliance), a Randomized Neoadjuvant Phase III Trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-Positive Breast Cancer

URL

Google Scholar

Citation:: Cancer Res vol 77 (4 suppl) Abstract nr S3-05

Meeting Instance:: SABCS 2016
Year:: 2017
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 2809 3314

Program:: TRP
Primary Committee:: Sequencing
Sec. Committees:: Breast

Pharmas:
Grants:: U10CA031946, U10CA033601, U10CA180821, U10CA180882

Corr. Author:
Authors:: Maki Tanioka Chen Fan Lisa A. Carey Terry Hyslop Brandelyn Pitcher Joel S. Parker Katie Hoadley N. Lynn Henry Sara Tolaney Chau Dang Ian E. Krop Lyndsay Harris Donald A. Berry Elaine Mardis Charles M. Perou Eric P Winer Clifford A Hudis

Networks:: LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NY016, LAPS-UT003

Study: CALGB-40601
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: